logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Staphylococcus Aureus Infection

    FiltersReset Filters
    5 results

    • daptomycin

      (Daptomycin)
      BluePoint Laboratories
      Usage: Daptomycin for injection is indicated to treat complicated skin and skin structure infections in adults and children (1-17 years) caused by specific Gram-positive bacteria, and bloodstream infections (bacteremia) due to Staphylococcus aureus in adults and pediatric patients. It is not indicated for pneumonia or left-sided infective endocarditis.

    • daptomycin

      (daptomycin)
      Mylan Institutional LLC
      Usage: Daptomycin for injection is indicated for treating complicated skin and skin structure infections in adults and pediatric patients (1-17 years) caused by susceptible Gram-positive bacteria, and for Staphylococcus aureus bloodstream infections (bacteremia) in both adult and pediatric patients. Not recommended for pneumonia or left-sided infective endocarditis.

    • daptomycin

      (daptomycin)
      Mylan Institutional LLC
      Usage: Daptomycin for injection is indicated for treating complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bloodstream infections (bacteremia) in adults and pediatric patients (1-17 years). It is not recommended for pneumonia or left-sided infective endocarditis and should not be used in patients younger than 1 year.

    • daptomycin

      (DAPTOMYCIN)
      Meitheal Pharmaceuticals Inc.
      Usage: Daptomycin for Injection is indicated for treating complicated skin and skin structure infections (cSSSI) and Staphylococcus aureus bloodstream infections (bacteremia) in adults and pediatric patients aged 1 to 17. It is not recommended for pneumonia or left-sided infective endocarditis, and usage is limited in patients under 1 year.

    • zevtera

      (ceftobiprole medocaril sodium)
      La Jolla Pharmaceutical Company
      Usage: ZEVTERA is indicated for treating adult patients with Staphylococcus aureus bloodstream infections, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia in pediatric patients (3 months to <18 years) caused by susceptible bacteria, including methicillin-resistant strains.